Microglial proliferation and monocyte infiltration contribute to microgliosis following status epilepticus
Male
Neurons
0303 health sciences
Kainic Acid
Cell Death
Receptors, CCR2
Calcium-Binding Proteins
Microfilament Proteins
CX3C Chemokine Receptor 1
Mice, Transgenic
Receptor, Macrophage Colony-Stimulating Factor
Hippocampus
Monocytes
Mice, Inbred C57BL
Tissue Culture Techniques
Disease Models, Animal
03 medical and health sciences
Status Epilepticus
Animals
Gliosis
Microglia
Cell Proliferation
DOI:
10.1002/glia.23616
Publication Date:
2019-04-06T04:43:28Z
AUTHORS (11)
ABSTRACT
AbstractMicroglial activation has been recognized as a major contributor to inflammation of the epileptic brain. Seizures are commonly accompanied by remarkable microgliosis and loss of neurons. In this study, we utilize the CX3CR1GFP/+ CCR2RFP/+ genetic mouse model, in which CX3CR1+ resident microglia and CCR2+ monocytes are labeled with GFP and RFP, respectively. Using a combination of time‐lapse two‐photon imaging and whole‐cell patch clamp recording, we determined the distinct morphological, dynamic, and electrophysiological characteristics of infiltrated monocytes and resident microglia, and the evolution of their behavior at different time points following kainic acid‐induced seizures. Seizure activated microglia presented enlarged somas with less ramified processes, whereas, infiltrated monocytes were smaller, highly motile cells that lacked processes. Moreover, resident microglia, but not infiltrated monocytes, proliferate locally in the hippocampus after seizure. Microglial proliferation was dependent on the colony‐stimulating factor 1 receptor (CSF‐1R) pathway. Pharmacological inhibition of CSF‐1R reduced seizure‐induced microglial proliferation, which correlated with attenuation of neuronal death without altering acute seizure behaviors. Taken together, we demonstrated that proliferation of activated resident microglia contributes to neuronal death in the hippocampus via CSF‐1R after status epilepticus, providing potential therapeutic targets for neuroprotection in epilepsy.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (58)
CITATIONS (78)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....